TB

The Becker Group

North America, Maryland, United States, Baltimore

Description

Transforming venues into a virtual wonderland.

Investor Profile

The Becker Group has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series F rounds (top funding stages).
  • Majority of deals are located in Israel.
  • Strong thematic focus on Biotechnology, Clinical Trials, Therapeutics.

Stage Focus

  • Series F (100%)

Country Focus

  • Israel (100%)

Industry Focus

  • Biotechnology
  • Clinical Trials
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does The Becker Group frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 1
Integra Holdings
Europe, Zurich, Switzerland, Wallisellen
Co-Investments: 1
Lundbeckfonden Ventures
Europe, Hovedstaden, Denmark, Copenhagen
Co-Investments: 1
Asahi Kasei
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
Arix Bioscience
Europe, England, United Kingdom, London
Co-Investments: 1
SR One
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
Adams Street Partners
North America, Illinois, United States, Chicago
Co-Investments: 1

What are some of recent deals done by The Becker Group?

Atox Bio

Ness Ziona, HaMerkaz, Israel

Atox Bio is a biotechnology company that specializes in infectious diseases, immunomodulators, and critical care.

BiotechnologyClinical TrialsTherapeutics
Series FDec 4, 2017
Amount Raised: $30,000,000